uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Role of the Dorsal Striatum and 5-HT2A receptor in a mouse model of autism
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
2015 (English)Independent thesis Advanced level (professional degree), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

BACKGROUND: Some cases of autism spectrum disorder (ASD) are associated with genetic causes. A micro deletion on the human chromosome 16p11.2 is the most common. A mouse model with this deletion demonstrates functional abnormalities in the basal ganglia (BG), mainly the striatum. 5-HT2A receptors are also present in the striatum and may provide substrate for modulating the BG circuitry that possibly has a crucial role in ASD. AIM: To examine neuron activity in the striatum, qualitatively observe the distribution of the 5-HT2A receptor in the striatum and pharmacologically investigate serotonin 5-HT2A involvement in the behavioral abnormalities found in 16p11.2 deletion mice. METHODS: Expression of the gene product of c-fos was measured using immunohistochemistry to provide a measure of neural activity. Autoradiography was used to describe the distribution of the 5-HT2A receptors in the striatum. The effect of risperidone and M100907 on 16p11.2 deletion mice was assayed using the forced swim test. RESULTS: A significant increase in c-fos expression in the dorsal striatum in mutant mice was observed. Both normal and deletion mice exhibited receptor binding to 5-HT2A in the striatum. A significant decrease in mobility in the forced swim test in both mutant and wild type mice was observed only when risperidone was administrated compared to controls and M100907. CONCLUSION: Elevated c-fos expression in the dorsal striatum indicates altered activity in dorsal striatum in this ASD mouse model. 5-HT2A receptor binding in the striatum is qualitatively similar in both genotypes. Risperidone had a greater effect than M100907 in normalizing behavioral response in the swim, yet further dose-response and behavioral studies has to be done for more accurate determinations about the involvement of 5-HT2A as a possible pharmacological target for treatment in autism.

Place, publisher, year, edition, pages
Keyword [en]
Autism, 5-HT2A, dorsal striatum, c-fos
National Category
Pharmaceutical Sciences
URN: urn:nbn:se:uu:diva-242728OAI: oai:DiVA.org:uu-242728DiVA: diva2:784825
External cooperation
Boston Children's Hospital / Harvard Medical School
Subject / course
Pharmaceutical Biosciences
Educational program
Master of Science Programme in Pharmacy
Available from: 2015-02-02 Created: 2015-01-30 Last updated: 2015-02-02Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Pharmaceutical Biosciences
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 452 hits
ReferencesLink to record
Permanent link

Direct link